Yukari Tanaka

Yukari Tanaka

Auto-generated profile, based on publicly available information

Yukari Tanaka

Leader of Japan Association for Imaging Mass Spectrometry, Drug Metabolism and Pharmacokinetics and Analytical Sciences, Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd, 3-1-1 Futaba, Toyonaka, Osaka, 561-0825, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
ESEric Solon
Eric Solon
MGM. Reid Groseclose
M. Reid Groseclose
SHStacy Ho
Stacy Ho
KTKouji Tanaka
Kouji Tanaka
NNNaoyuki Nakada
Naoyuki Nakada
YTYukari Tanaka
Yukari Tanaka

5 May 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JOJunichiro Okada
Junichiro Okada
THTadashi Hisano
Tadashi Hisano
MUMitsuaki Unno
Mitsuaki Unno
YTYukari Tanaka
Yukari Tanaka
MSMamoru Saikusa
Mamoru Saikusa
OIOsuke Iwata
Osuke Iwata
Neonates often develop transition problems after low-risk birth, precise assessment of which is difficult at primary birth centres. The aim of this study was to assess whether a video triage system can be established without a specially designed communication system between local birth centres and a tertiary neonatal intensive care unit in a region with a population of 700,000. 761 neonates who were referred to a tertiary neonatal intensive care unit were examined. During period 1 (April 2011-August 2015), only a voice call was available for consultations, whereas, during period 2 (September 2015-December 2017), a video call was additionally available. The respiratory condition was assessed based on an established visual assessment tool. A video consultation system was established by connecting personal smartphones at local birth centres with a host computer at a tertiary neonatal intensive care centre. During period 2, video-based triage was performed for 42.4% of 236 consultations at 30 birth centres. Sensitivity and specificity for predicting newborns with critical respiratory dysfunction changed from 0.758 to 0.898 and 0.684 to 0.661, respectively. A video consultation system for ill neonates was established without major instalment costs. Our strategy might improve the transportation system in both high- and low-resource settings.

1 January 2010 in Oncology
Verified
Journal Article
Closed access
PDF file
BNBunzo Nakata
Bunzo Nakata
ATAkihito Tsuji
Akihito Tsuji
YMYasushi Mitachi
Yasushi Mitachi
NTNaoyuki Taenaka
Naoyuki Taenaka
TKToshiki Kamano
Toshiki Kamano
KHKosei Hirakawa
Kosei Hirakawa
Aims: The efficacy and the toxicity of oral fluorouracil derivative S-1 plus low-dose cisplatin in unresectable or recurrent gastric cancer were evaluated by a phase II study. Methods: S-1 was administered orally for 28 days following 14 days’ rest at 80–120 mg/body/day, depending on body surface area. During administration of S-1, cisplatin was given twice a week at the recommended dose (10 mg/m2), which was determined by a phase I study. Data from 34 patients in phase II and 8 patients treated with the recommended dose of cisplatin in phase I were analyzed. The primary endpoint was objective response. Results: The response rate was 47.1%. The median survival time was 11.0 months and the median progression-free survival was 6.9 months. The grade 3/4 toxicities observed in 10% or more of the treated patients were neutropenia (16.7%), anemia (16.7%) and anorexia (11.9%). The serum concentration of cisplatin was 794 ± 341 ng/ml at day 25 of the first course. Conclusions: S-1 plus low-dose cisplatin may be a clinically useful regimen for unresectable or recurrent gastric cancer because of its infrequent adverse events in spite of considerable efficacy and its convenience of no hydration and no hospitalization.


17 April 2025 in Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Open access
YTYukari Tanaka
Yukari Tanaka
HYHiroyuki Yokoi
Hiroyuki Yokoi
HKHidefumi Kaji
Hidefumi Kaji
YUYoko Urasaki
Yoko Urasaki
MNMasanobu Nishidate
Masanobu Nishidate
HYHiroshi Yamazaki
Hiroshi Yamazaki
Imaging mass spectrometry (IMS) is used in various fields of pharmaceutical research and development, including the targeted delivery of administered drugs, drug distribution in tissues, drug toxicity analysis, and disease mechanisms. However, IMS is a relatively new technology that requires further validation before being accepted by authorities for regulatory compliance of new drugs. In 2020, an international survey was conducted in collaboration with the Imaging Mass Spectrometry Society (IMSS) and the Japan Association for Imaging Mass Spectrometry (JAIMS) to understand the status of IMS and to identify problems with its application. The survey revealed technical challenges in sample preparation, quantitative analysis of drugs in tissues, and data acquisition. Based on the 2020 survey results, we recently conducted a further detailed survey and had discussions within the JAIMS aimed at translating the results into specific experimental procedures and proposing feasible standard methods. This survey involved detailed questions on five themes: sample collection and storage, tissue section preparation, sample preparation, data analysis (including quantitative analysis and data correction methods), and data reproducibility. The questions were answered by JAIMS members working for ten companies. To resolve technical issues identified by the survey, we propose some realistic approaches toward standardization.

4 January 2023 in Endoscopy
Verified
Journal Article
Open access
PDF file
NANobukazu Agatsuma
Nobukazu Agatsuma
TUTakahiro Utsumi
Takahiro Utsumi
HHHirokazu Higuchi
Hirokazu Higuchi
TITakahiro Inoue
Takahiro Inoue
YTYukari Tanaka
Yukari Tanaka
HSHiroshi Seno
Hiroshi Seno
Endoscopic clips, which are widely used for hemostasis and closure [1] [2], have recently been applied to other indications such as traction-assisted endoscopic submucosal dissection (ESD) [3]. Repositionable clips have been reported to be a promising option for any indication [4] [5]. Despite the adoption of clips that allow repeated opening and closing before clip deployment, endoscopists still encounter situations in which they want to remove the placed clip. Here, we present a novel removable clip (hemoclip, AG-51044-2300-090-16; Hangzhou AGS MedTech Co., Ltd., Hangzhou, China) that is repositionable and rotatable. The clip was detached by squeezing the thinning point at the end of the clip stem using a polypectomy snare ([Fig. 1]). This video shows the usefulness of novel removable endoscopic clips in failure of the traction method during gastric ESD in in vivo porcine models ([Video 1]). The new clip, using a clip-with-line method, accidentally grasped both the edge of the lesion and the muscle layer, making it difficult to continue ESD safely. However, the mistakenly placed clip was able to be easily removed using a polypectomy snare (AG-5078–241023; Hangzhou AGS MedTech Co., Ltd) ([Fig. 2]). Then, a clip with a ring-loaded spring (S-O clip, TC1H05; Zeon Medical Co., Ltd., Tokyo, Japan) was used for the traction method during ESD. The removable clip captured the loop part of the S-O clip and anchored it to the gastric wall. However, the misplaced clip did not provide a good field of vision or adequate tension in the submucosal dissection plane. The clip was removed using a snare, and a new clip was anchored to the proper position ([Fig. 3]). It is possible to perform the procedure again using a removable clip, even when closing the clip results in a risky or ineffective situation. Video 1 Demonstration of the usefulness of novel removable endoscopic clips in failure of the traction method during endoscopic submucosal dissection in a porcine model. Endoscopy_UCTN_Code_TTT_1AQ_2AD Article published online: 15 September 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany